1Mehnert W, Mader K. Solid lipid nanopartictes: Production, characterization and applications[J]. Adv Drug Del Rev, 2006,47(2-3) : 165-196.
2Wrte G, Siekmann B, Bunjes H. Effect of drug loading on the transformation of vesicular into cubic nanopartictes during heat treatment of aqueous monootein/potoxame dispersions [J]. Fur J Pharm Biopharm , 2006, 63:128-133.
4Hu FQ, Hong Y; Yuan H. Preparation and charaterization of solid lipid nanopartictes containning peptide [ J]. Int J Pharm , 2006,273(2) : 29-35.
5Gohia S, Dingier A. Scaling UP feasibility of solid lipid nanoparticles (SLN)[J]. Pharrnazie , 2006,56:61-68.
6Fuentes MG, Atonso MJ, Torres D. Design and characterization of a new drug nanocarrier made from solid-lipid nanoparitictes mistures[J]. J Col Int Sci , 2005,285:590-598.
7Oner M,Wissing SA,Yener G, et al . Influence of surfactants on the physical stability of solid lipid nanoparticte(SLN)formulations[J]. Pharmazie ,2004,59(4) :331-338.
8Spicer PT. Progress in liquid crystalline dispersions: Cubosomes[J]. CurrOpin Colloid Interface Sci ,2005,10: 274.
9Freitas C, Muller R. Spray-drying of solid lipid nanopartictes (SLN)[J]. Fur J Pharm Biopharm , 2008,46:145-151.
10Castetti F, Bobiba F, Pugtia C, et al . Characterization of indomethacin-toaded lipid nanopartictes by differential scanning calorimetry[J]. Int J Pharm ,2005,304 : 231-238.
5[1]Muller RH, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles(SLN)-an alternative colloidal carrier system for controlled drug delivery [J]. Eur J Pharm Biopharm, 1995,41(1):62-69.
6[2]De Vringer T, de Ronde HAG. Preparation and structure of a water-in-oil cream containing lipid nanoparticles [J]. J Pharm Sci, 1995,84(4):466-472.
7[3]Schwarz C, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization [J]. J Controlled Release, 1994,30(1):83-96.
8[4]Yang SC, Lu LF, Cai Y, et al. Body distribution in mice of intraveneously injected camptothecin solid lipid nanoparticles and targeting effect on brain [J]. J Controlled Release, 1999,59(3):299-307.
9[5]Annette M, Schwarz C, Mehnert W. Solid lipid nanoparticles(SLN) for controlled drug delivery-drug release and release mechanism [J]. Eur J Pharm Biopharm, 1998,45(2):149-155.
10[6]Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution [P]. US Pat: 5250236,1993-10-05.
